Parham Eshtehardi MD
LightNews LightNews
banner
cardioobdoc.bsky.social
Parham Eshtehardi MD
@cardioobdoc.bsky.social
2.4K followers 1.2K following 1.4K posts
Preventive, Imaging, CardioOB Cardiologist & Scientist • Dad • Husband of a Stroke & Cancer Survivor Hero • Emory Trained • Atlanta, GA
#CardioSky #CardioObstetrics #ACCRepOB #ACCCardioOB

🔗 bit.ly/MyResearchPubs
Posts Replies Media Videos
Pinned
cardioobdoc.bsky.social
Parham Eshtehardi MD @cardioobdoc.bsky.social · Nov 22
#Skytorial for #CardioSky #MedSky newcomers
1/2

🦋 Follow #CardioSky community by using starter packs:
Cardio Journals & Societies
go.bsky.app/FfE1QRm
CardioSky I
go.bsky.app/562nfhZ
CardioSky II
go.bsky.app/R2XckyG

🦋 Add label "Cardiology" to your profile w/labeler
bsky.app/profile/meds...
Reposted by Parham Eshtehardi MD
thaithanhnha.bsky.social
Coronary revascularization: a long-term perspective .

academic.oup.com/eurheartj/ad...

@escardio.bsky.social
#CardioSky
November 27, 2025 at 12:55 PM
Reposted by Parham Eshtehardi MD
scainews.bsky.social
Who's excited for Montreal?🙋‍♂️Registration for #SCAI2026 is live! Learn about the latest #InterventionalCardiology breakthroughs at our premier conference on April 23-25, 2026.

Save now with our special Advance Registration discount available through Jan. 7➡️ https://ow.ly/pnzW50XxHnA

#CardioSky
November 27, 2025 at 1:03 PM
Reposted by Parham Eshtehardi MD
eurointervention.bsky.social
Long-term outcomes after BE-TAVI appear independent of annular size. In 2,699 patients, mortality and BVF at 7 years were similar between small and large annuli.
#TAVI #StructuralHeart #cardiosky
eurointervention.pcronline.com/article/long...
November 27, 2025 at 2:31 PM
Reposted by Parham Eshtehardi MD
scct-heart.bsky.social
Cardiovascular Business reports: @roosha.bsky.social explains SCCT advocacy efforts to increase CCTA AI plaque reimbursements.

Read the article: cardiovascularbusiness.com/video/2025-1...

#yesCCT #cardiosky
Roosha Parikh explains SCCT advocacy efforts to increase CCTA AI plaque reimbursements | Cardiovascular Business
cardiovascularbusiness.com
November 27, 2025 at 7:14 PM
Reposted by Parham Eshtehardi MD
scainews.bsky.social
🕰️It's time to select the next SCAI leaders who will shape our society and strengthen the field of #InterventionalCardiology. Nominations are now open for multiple positions, and we encourage you to participate!

View positions and nominate by January 7 ➡️ https://ow.ly/7bYe50XxK6u

#CardioSky
November 28, 2025 at 1:01 PM
Reposted by Parham Eshtehardi MD
accintouch.bsky.social
🦃 This Thanksgiving, we're grateful for the heart of our Mission: ACC's 60,000+ members around the world transforming CV care & improving heart health for all! 🫀

➡️ Share & tag a colleague or mentor you're thankful for today!

#ACCMember #CardioSky
November 27, 2025 at 3:52 PM
Reposted by Parham Eshtehardi MD
natrevcardiol.nature.com
New online! PCSK9 inhibition for primary prevention of cardiovascular events #CardioSky
PCSK9 inhibition for primary prevention of cardiovascular events
Nature Reviews Cardiology, Published online: 25 November 2025; doi:10.1038/s41569-025-01240-0In the VESALIUS-CV trial, the PCSK9 inhibitor evolocumab reduced the risk of a first cardiovascular event in patients with atherosclerosis or diabetes mellitus but without a previous myocardial infarction or stroke.
bit.ly
November 25, 2025 at 7:56 PM
Reposted by Parham Eshtehardi MD
accintouch.bsky.social
With ASCs continuing to emerge as alternatives to hospital-based care, “appropriately selected procedures in the field of #cvEP … could increasingly shift to an ASC setting,” according to a 🆕 HRS/ACC Scientific Statement.

Read more: https://bit.ly/48A6oHC #JACC #CardioSky @jaccjournals.bsky.social
November 25, 2025 at 8:07 PM
Reposted by Parham Eshtehardi MD
eurointervention.bsky.social
New data from the OCEAN-TAVI CT substudy highlight the role of THV deformation and asymmetric leaflet expansion as key predictors, with greater HALT burden linked to higher gradients. #cardiosky #THV #stucturalcardiology
eurointervention.pcronline.com/article/inci...
November 23, 2025 at 9:29 AM
Reposted by Parham Eshtehardi MD
haoyin.bsky.social
#RNAEditing #PulmonaryArterialHypertension

ADAR1 (both p150 & p110 isoforms) ⬇️in 👤PAH (in 🫁vascular smooth muscle cell)

SMC ADAR1 KO🐭 excerbates PAH

SMC ⏫dsRNA➡️⏫PKR-eIF2B-IFNβ➡️
Macrophage M1 polarization➡️
SMC proliferation

@kekeyuan.bsky.social #CircRes 2025
www.ahajournals.org/doi/10.1161/...
November 23, 2025 at 12:37 PM
Reposted by Parham Eshtehardi MD
scainews.bsky.social
💡A new study shows that early #TAVR in asymptomatic severe aortic stenosis not only improves outcomes, but also cuts costs. Learn more about the results of the EARLY TAVR study in this Cardiovascular Business article➡️ https://ow.ly/f0H850XuTst

#CardioSky
Early TAVR for asymptomatic severe AS cuts costs, improves outcomes
The study found lifetime per-patient savings from early TAVR ranged from about $2,334 in the U.K. to $19,607 in Switzerland.
ow.ly
November 23, 2025 at 4:00 PM
Reposted by Parham Eshtehardi MD
nejm.org
In patients with cardiovascular disease and an implantable cardioverter–defibrillator, increasing potassium levels to the high-normal range reduced the risk of arrhythmia events, hospitalizations, and death. Full POTCAST trial results: nej.md/4oQtHTN

#MedSky #CardioSky
November 23, 2025 at 8:01 PM
Reposted by Parham Eshtehardi MD
lruggiero.bsky.social
Social Determinants of Cardiovascular Aging
www.jacc.org/doi/10.1016/...
November 24, 2025 at 11:51 AM
Reposted by Parham Eshtehardi MD
thaithanhnha.bsky.social
New insights into the management of fulminant myocarditis

academic.oup.com/eurheartj/ad....

@escardio.bsky.social
#CardioSky #EHJ
November 24, 2025 at 12:40 PM
Reposted by Parham Eshtehardi MD
scainews.bsky.social
⚡SCAI's recently announced Door to Lactate Clearance initiative aims to improve #CardiogenicShock outcomes by measuring and reducing lactate levels. Learn more by watching this Cardiovascular Business interview with SCAI President Srihari Naidu, MD, MSCAI ➡️ https://ow.ly/lUMa50XuOCV

#CardioSky
SCAI: To improve cardiogenic shock outcomes, reduce lactate levels
SCAI feels this is the best way forward to try lowering mortality rates, but the group is asking cardiologists to help by gathering more data. 
ow.ly
November 24, 2025 at 1:01 PM
Reposted by Parham Eshtehardi MD
drdavemd.bsky.social
I appreciate that in this scientific statement on epicardial coronary physiological measurements, the authors expressly state that using angiographic assessment alone is only slightly better than a coin flip. www.ahajournals.org/doi/10.1161/... #cardiosky @sripalbangalore.bsky.social
November 24, 2025 at 1:41 PM
Reposted by Parham Eshtehardi MD
kardioklick.bsky.social
You can do a cath a day before an MI and see nothing remarkable. I've witnessed it several times.

The holy grail of cardiology.

#cardiosky

Limitations of Risk- and Symptom-Based Screening in Predicting First Myocardial Infarction | JACC: Advances www.jacc.org/doi/10.1016/...
Limitations of Risk- and Symptom-Based Screening in Predicting First Myocardial Infarction:
www.jacc.org
November 24, 2025 at 2:52 PM
Reposted by Parham Eshtehardi MD
womenasone.bsky.social
Dr Stacey Rosen called out decades of neglect in women’s heart health during her speech at #AHA25 and celebrated the power of advocacy, research, and allies.

True equity means every woman gets timely, life-saving care. ❤️

www.youtube.com/watch?v=qeCz...
#Cardiosky #WomensHealth
2025 Conner Lecture - Stacey Rosen, MD, FAHA
YouTube video by AHAScience
www.youtube.com
November 24, 2025 at 4:27 PM
Reposted by Parham Eshtehardi MD
accintouch.bsky.social
Step into the Personalized Skills Zone at #ACC26 to sharpen your clinical & procedural skills through hands-on education. Explore interactive simulation stations, attend small stage expert-led sessions, & more.

Find out more & join us at ACC.26 ➡️ https://bit.ly/43OMZAh #CardioSky #MedSky
November 24, 2025 at 5:14 PM
Reposted by Parham Eshtehardi MD
jaccjournals.bsky.social
New HRS/ACC scientific statement outlines guiding principles for performing intracardiac ablation procedures in ASCs, highlighting their growing role, evidence for safe use in select patients, & key regulatory & operational standards. https://bit.ly/4psqysT #CardioSky #JACC #epAblation
November 24, 2025 at 5:51 PM
Reposted by Parham Eshtehardi MD
accintouch.bsky.social
Has mentorship helped shape your CV journey? Ready to share your expertise? Apply to be a mentor for the #ACCIMProgram ➕ Pediatric Residents Cardiology Programs and guide the next generation of #cardiovascular professionals!

Due Dec. 10 👉 https://bit.ly/472nhdW #ACCHealthEquity #cvPed #CardioSky
November 24, 2025 at 6:14 PM
Reposted by Parham Eshtehardi MD
jaccjournals.bsky.social
The latest update from the #GBDStudy not only reveals the current state of #CVD on a global scale, but also points to the interventions that can help accelerate progress.

This week's #JACC focus issue reflects on how these findings can guide the future of CV care. https://bit.ly/47Z4Nep #CardioSky
November 24, 2025 at 6:45 PM
Reposted by Parham Eshtehardi MD
mgh-id.bsky.social
www.jacc.org/doi/10.1016/...
The Role of Multimodality Cardiac Imaging in the Diagnosis and Management of Chronic Chagas Cardiomyopathy:
www.jacc.org
November 24, 2025 at 8:04 PM
Reposted by Parham Eshtehardi MD
jaccjournals.bsky.social
📸 JACC Journals were honored to join QICC 2025 in Hangzhou, China last week where leaders, including JACC Editor-in-Chief Dr. Harlan Krumholz, gathered to bridge global innovation in cardiovascular science. 🫀

Get the science published in #JACC here: https://bit.ly/48c9EHX

#CardioSky #JACCJournals
November 24, 2025 at 8:57 PM
Reposted by Parham Eshtehardi MD
ajpcardio.bsky.social
New paper: Risk matters for ASCVD — but vascular resilience may decide the outcome. Insightful work by American Society for Preventive Cardiology President Dr. Michael D. Shapiro & Dr. Khurram Nasir on why not all high-risk patients experience events.
https://ow.ly/6cfj50XxfnQ
#CardioSky #MedSky
November 24, 2025 at 11:41 PM